The NCEP ATP III guidelines: Friend or foe?

Preventive Cardiology

Volumn 5, Issue 3, 2002, Pages 152-155

  McBride, Patrick E ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b H6/319 CSC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH EDUCATION; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; PRACTICE GUIDELINE; PRIMARY PREVENTION; REFERENCE VALUE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; MALE; MIDDLE AGED; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STANDARD;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HEALTH EDUCATION; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0036626924     PISSN: 1520037X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1520-037X.2002.01689.x     Document Type: Review

References (8)

1. NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA. 2001;285:2486-2497.
2. Whayne TF Jr, Zielke JC. Problems with the new Adult Treatment Panel III guidelines. Prev Cardiol. 2002;5:91.
3. Blum CB. Some thoughts on the Adult Treatment Panel III Report. Prev Cardiol. 2002;5:87-89, 93.
4. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-1622.
5. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
6. [No authors listed]. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at an increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J. 1998;20(10):725-741.
7. McBride P, Underbakke G, Plane MB, et al. Improving practice prevention systems in primary care: The Health Education and Research Trial (HEART). J Fam Pract. 2000;49:115-125.
8. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 2001;24(suppl):S58-S61.